Step by Step

INTRODUCTION

ABIM MOC Activity ID

2/28/2023 - Medical Grand Rounds: Iron Metabolism, Erythropoiesis, and Sickle Cell Disease

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Describe some of the gaps in iron regulation in the red cell.
  • Outline some of the limitations of iron supplementation in treating iron deficiency.
  • Identify the multiple etiologies of anemia in sickle cell disease.

Suggested Additional Reading & Joint Accreditation Statement - Note: This Accreditation Statement Supersedes All Other Statements:

Suggested additional reading:

  1. Yien YY, Perfetto M (2022). Regulation of heme synthesis by mitochondrial homeostasis proteins. Front. Cell. Dev. Biol. doi: 10:895521/fcell.2022.895521. PMID 35832791.
  2. Xu JZ and Thein SL. Blood. 2022;139(20):3030-3039.
  3. Ganz and Nemeth. Biochim Biophys Acta. 2012 Sep;1823(9):1434-43.

Joint Accreditation Statement

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This educational activity is approved for 1.0 contact hours.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Authors:
Julia Z. Xu, MD, MScGH — Assistant Professor of Medicine, Division of Hematology/Oncology, Section of Benign Hematology Vascular Medicine Institute, Department of Medicine, University of Pittsburgh
Dr. Xu is a consultant with GSK.
Yvette Yien, PhD — Vascular Medicine Institute, Department of Medicine, University of Pittsburgh School of Medicine
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.